L695-0606 Screening compound: 1-methyl-6-(morpholine-4-sulfonyl)-3-[3-oxo-3-(piperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinazoline-2,4-dione

L695-0606 Screening compound: 1-methyl-6-(morpholine-4-sulfonyl)-3-[3-oxo-3-(piperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinazoline-2,4-dione
L695-0606 Screening compound: 1-methyl-6-(morpholine-4-sulfonyl)-3-[3-oxo-3-(piperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinazoline-2,4-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound L695-0606
1-methyl-6-(morpholine-4-sulfonyl)-3-[3-oxo-3-(piperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinazoline-2,4-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L695-0606

Molecular Formula

C21H28N4O6S (C21 H28 N4 O6 S)

Compound Name

1-methyl-6-(morpholine-4-sulfonyl)-3-[3-oxo-3-(piperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinazoline-2,4-dione

IUPAC name

1-methyl-6-(morpholine-4-sulfonyl)-3-[3-oxo-3-(piperidin-1-yl)propyl]-1234-tetrahydroquinazoline-24-dione

SMILES

CN(c(ccc(S(N1CCOCC1)(=O)=O)c1)c1C(N1CCC(N2CCCCC2)=O)=O)C1=O

InChI

InChI=1S/C21H28N4O6S/c1-22-18-6-5-16(32(29,30)24-11-13-31-14-12-24)15-17(18)20(27)25(21(22)28)10-7-19(26)23-8-3-2-4-9-23/h5-6,15H,2-4,7-14H2,1H3

InChI Key

NTYQZQPLSRCHJI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27470574

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.54

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.698

Distribution Coefficient, logD

0.698

Water Solubility, LogSw

-2.47

Polar Surface Area

87.294

Acid Dissociation Constant (pKa)

23.94

Base Dissociation Constant (pKb)

-0.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

57.10

L695-0606 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L695-0606 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L695-0606?
Check Price and Availability of L695-0606, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L695-0606 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L695-0606
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L695-0606
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L695-0606 available by request